Anti-Aging · Reference
Can You Take Epithalon With Tirzepatide or Semaglutide?
This page covers what each medication is, what is known about using them together, the cancer-history question, what overlaps in the early weeks, how the schedules fit, and how to add Epithalon properly. Everything here applies to semaglutide the same way.

Epithalon can be prescribed alongside tirzepatide or semaglutide when a physician reviewing your intake judges it appropriate, but no study has tested the combination. The two have nothing in common mechanically: tirzepatide acts on appetite and gastric emptying through the GIP and GLP-1 receptors, while Epithalon is a four-amino-acid peptide described in cell and animal work around telomerase and evening melatonin. There is no established interaction list for Epithalon. The point that matters most is cancer history, which both medications raise for different reasons and which belongs on your intake in full.
This page covers what each medication is, what is known about using them together, the cancer-history question, what overlaps in the early weeks, how the schedules fit, and how to add Epithalon properly. Everything here applies to semaglutide the same way.
Can You Take Epithalon With Tirzepatide or Semaglutide?
The short answer
| Question | Answer |
|---|---|
| Can they be prescribed together? | Yes, when a physician reviewing your intake judges it appropriate |
| Has the combination been studied? | No |
| Do they act on the same system? | No. Tirzepatide acts at the GIP and GLP-1 receptors; Epithalon is described around telomerase in cultured cells and melatonin rhythm in animals and older people |
| Is there an established interaction? | No interaction list exists for Epithalon, because the trials that would produce one have not been run |
| Does Epithalon affect weight or appetite? | In the anchor mouse lifespan study it did not change food intake or body weight |
| What needs raising first? | Any personal or strong family history of cancer, including thyroid cancer |
| Same answer for semaglutide? | Yes |
The medications this page covers:
| Product | What is in it | Typical directions | Price |
|---|---|---|---|
| Epithalon | 5 mL multi-dose vial, Epithalon 2 mg/mL (10 mg per vial) | 0.25 mL (25 units) under the skin once daily, Monday through Friday | $249/mo |
| Tirzepatide | Dose-specific 2 mL vials at six strengths, 2.5 mg to 15 mg weekly; glycine in the 2.5 mg and 7.5 mg vials | 0.50 mL (50 units) once weekly at every strength | From $159/mo |
| Semaglutide | Dose-specific vials at six strengths, starting with 1 mg per 1 mL at the 0.25 mg starting dose | Printed on the vial for your strength | From $99/mo |
Prices are all-in, covering medication, physician review, refill management and shipping, with no membership fee. GLP-1 prices are "from" prices, set by dose. Compounded medications are not FDA approved.
Can You Take Epithalon With Tirzepatide or Semaglutide?
Two medications with different questions behind them
Tirzepatide
Tirzepatide is a single peptide that activates the GIP and GLP-1 receptors. It acts on appetite centres in the brain, slows gastric emptying and changes insulin and glucagon signalling, and it has a very large human trial base in its approved form. See what is tirzepatide.
Epithalon
Epithalon is a tetrapeptide, Ala-Glu-Asp-Gly, designed in the 1990s in St Petersburg to reproduce the composition of a bovine pineal extract called Epithalamin. Its best-known finding is from cultured human cells: a 2003 paper reported it inducing telomerase and lengthening telomeres, and a 2025 independent replication from Brunel University London reported the same in normal human cell lines. In old rhesus monkeys it raised evening melatonin and lowered evening cortisol. It is not melatonin, not a sedative and not a hormone. See what is Epithalon.
Side by side
Tirzepatide Epithalon What it is A dual GIP and GLP-1 receptor agonist A four-amino-acid pineal-derived peptide Described target Appetite, gastric emptying, insulin and glucagon Telomerase in cultured cells; evening melatonin where output is low Effect on weight in its research The trial endpoint of the approved product None: the 2003 mouse lifespan study found no change in food intake or body weight Human evidence Large randomised trials of the approved product Small, old, mostly from one research network, largely using the parent extract; no randomised trials of the injectable Schedule at Pepti Once weekly, continuously Once daily Monday through Friday, in courses FDA status Compounded versions are not FDA approved Removed from Category 2 in April 2026; advisory committee voted 7 to 4 to recommend it for the Bulks List in July 2026, final determination pending There is no shared receptor or described pathway, so a direct interaction is not expected on mechanism. With no study of the pairing, that is as far as the evidence goes.
Can You Take Epithalon With Tirzepatide or Semaglutide?
The cancer-history question
When both medications are on the table, this is the conversation to have first.
| Tirzepatide and semaglutide | Epithalon | |
|---|---|---|
| The concern | A boxed warning: thyroid C-cell tumors in rodent studies, with human relevance unknown | Telomerase activation is the mechanism by which cells escape senescence; the 2025 Brunel paper also reported telomere extension in breast cancer cell lines |
| What is known in people | Not shown to cause cancer in humans; two large human studies point different ways | No human safety study, no pharmacokinetic data and no adverse-event reports, which is an absence of data, not evidence of safety |
| The practical rule | A personal or family history of medullary thyroid carcinoma or MEN 2 rules both GLP-1s out | A personal or strong family history of cancer should be raised explicitly, and a reasonable physician may decline |
The FDA's July 2026 review flagged continuous, long-term telomerase activation as its specific concern, and noted that the rodent work which found fewer tumours used intermittent courses. That is why Epithalon is prescribed as a course rather than an open-ended daily medication, which is a real difference from a GLP-1, typically taken continuously. More on how the question is handled across peptides is in can peptides cause cancer.
Can You Take Epithalon With Tirzepatide or Semaglutide?
What overlaps in the early weeks
| Symptom | On tirzepatide | On Epithalon |
|---|---|---|
| Nausea, reflux, constipation | The most common effects, around starting and dose increases | Not described |
| Fatigue | 5 to 7% on the approved weight-management label, against 3% on placebo | Some early drowsiness is reported and usually settles |
| Vivid dreams | Not in the label figures | Reported by some people early on |
| Injection-site redness | 6 to 8% on the label | The most common prescriber report |
Early tiredness could come from either medication, and on a GLP-1 it often comes from eating and drinking much less than before. Start Epithalon when your GLP-1 dose is steady rather than in the week of an increase, so a change has one plausible cause. Time of day for Epithalon is worth asking your physician about, since the animal work involved shifts in evening hormone levels. The GLP-1 side-effect reference is tirzepatide side effects.
Can You Take Epithalon With Tirzepatide or Semaglutide?
Fitting the schedules together
| Epithalon | Tirzepatide | |
|---|---|---|
| Draw | 0.25 mL (25 units on a U-100 insulin syringe) | 0.50 mL (50 units) |
| Medication per dose | 0.5 mg Epithalon | Your weekly strength, 2.5 mg to 15 mg |
| How often | Once daily, Monday through Friday | Once weekly, same day each week |
| Doses per vial | 20 | 4 |
| One vial lasts | About four weeks | Four weeks |
The Epithalon figures are math from the vial: 0.25 mL of a 2 mg/mL solution is 0.5 mg, and 5 mL at 0.25 mL is 20 doses, five a week for four weeks. Both run on a 28-day refill cycle, one vial per fill.
- Two vials, two syringes, two sites. Never mix them in one syringe; each label was calculated against its own concentration.
- Keep your tirzepatide day fixed. If it is a weekday, both injections happen that day at different sites.
- Refrigerate both. The FDA's briefing noted reconstituted Epithalon is stable for only days at fridge temperature in the manufacturer's data, so the beyond-use date on the pharmacy label governs.
Epithalon inside the ETERNAL blend
Epithalon is also one of four agents in the ETERNAL Blend, with GHK-Cu, BPC-157 and TB-500, at $279 a month. If you already take ETERNAL, a separate Epithalon vial would duplicate it; tell your physician everything you take.
Can You Take Epithalon With Tirzepatide or Semaglutide?
Who should discuss it first
| Situation | Why |
|---|---|
| Personal history of cancer | Raised before Epithalon; a reasonable physician may decline |
| Strong family history of cancer | Needs discussion before Epithalon |
| Personal or family history of medullary thyroid carcinoma or MEN 2 | Rules out tirzepatide and semaglutide |
| Pregnancy, planning pregnancy or breastfeeding | Neither is used |
| A diagnosed sleep problem | Epithalon has no evidence in insomnia; the diagnosis comes first |
| Insulin or a sulfonylurea | Low blood glucose on tirzepatide becomes more likely |
| Oral contraceptives | May be absorbed less reliably for four weeks after starting tirzepatide and after each dose increase |
| Tested athlete | Many peptides are prohibited in competition; check your sport's list |
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Can You Take Epithalon With Tirzepatide or Semaglutide?
Semaglutide works the same way
Semaglutide acts at GLP-1 only, where tirzepatide acts at GLP-1 and GIP, and it carries the same boxed thyroid warning and the same early side effects. Everything above applies to it unchanged. Semaglutide and tirzepatide are never taken together; see semaglutide vs tirzepatide.
Can You Take Epithalon With Tirzepatide or Semaglutide?
How to add Epithalon to a GLP-1 properly
- Be clear about the goal. Epithalon's research concerns telomerase in cells and melatonin rhythm, not weight, energy or appearance. Nothing about telomeres is something you can feel or reliably test at home.
- Put your full cancer history on the intake, personal and family, including type.
- Start when your GLP-1 dose is steady.
- Expect a defined course. Repeat courses are set by your physician; do not improvise a permanent schedule.
Your physician sets your directions after reviewing your intake, and every vial arrives with its directions printed on the label. More on combining is in can you take two peptides together and what peptides can you take with tirzepatide. Step-by-step: how to get Epithalon prescribed and how to get tirzepatide prescribed.
Can You Take Epithalon With Tirzepatide or Semaglutide?
What the evidence shows, honestly
Tirzepatide has a large human evidence base in its approved form. Epithalon has cell work on telomerase now replicated independently, primate and rodent studies, and a human evidence base that is small, old, almost entirely from one research network, and largely generated with the parent extract. There are no randomised trials of injectable Epithalon for any indication and no study of it with any GLP-1. The two target unrelated systems, which makes the pairing reasonable to discuss, and the honest description of the combination is "unstudied."
References
What this is based on.
References
- Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine (2021) · PMID 33567185
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) · New England Journal of Medicine (2023) · PMID 37952131
- Wadden TA, Bailey TS, Billings LK, et al.. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity (STEP 3) · JAMA (2021) · PMID 33625476
- Rubino D, Abrahamsson N, Davies M, et al.. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial · JAMA (2021) · PMID 33755728
- Marso SP, Bain SC, Consoli A, et al.. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) · New England Journal of Medicine (2016) · PMID 27633186
- Davies M, Færch L, Jeppesen OK, et al.. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial · The Lancet (2021) · PMID 33667417
- Garvey WT, Batterham RL, Bhatta M, et al.. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial · Nature Medicine (2022) · PMID 36216945
- Rubino DM, Greenway FL, Khalid U, et al.. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial · JAMA (2022) · PMID 35015037
- Aronne LJ, Horn DB, le Roux CW, et al.. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) · New England Journal of Medicine (2025) · PMID 40353578
- Sanyal AJ, Newsome PN, Kliers I, et al.. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis (ESSENCE) · New England Journal of Medicine (2025) · PMID 40305708
- Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K et al.. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension · Diabetes Obes Metab (2022) · PMID 35441470
- Batsis JA, Gavras A, Gross DC, Cheever CR, Da Silva BR et al.. Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition: A Systematic Review · Ann Intern Med (2026) · PMID 41996180
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Can You Take Epithalon With Tirzepatide or Semaglutide?, answered.
It can be prescribed alongside tirzepatide when a physician reviewing your intake judges it appropriate. The two act on unrelated systems, but no study has tested the combination.
The answer is the same, with the same cancer-history questions.
No interaction is described, and no interaction list exists for Epithalon because the trials have not been run. Your physician reviews everything you take.
Nothing suggests it does. In the 2003 mouse lifespan study it did not change food intake or body weight, and it is not a weight treatment.
GLP-1 medications carry a boxed warning about thyroid C-cell tumors in rodents, and a history of medullary thyroid carcinoma or MEN 2 rules them out. Epithalon activates telomerase in cells, the mechanism by which cells escape senescence, and there is no human safety data.
Epithalon is prescribed in courses because the FDA flagged continuous telomerase activation as a concern and the research used intermittent courses. Your physician sets the course; tirzepatide is usually continuous.
Yes, as two separate injections from two separate vials, each with its own syringe and at a different site.
There is no study of Epithalon in people with insomnia. If sleep is the problem, tell your care team what is waking you; peptides for sleep covers the options.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.


